Skip to main content
Celularity Inc. (CELU)
NASDAQ: CELU · Real-Time Price · USD
1.450
-0.100 (-6.45%)
At close: Nov 6, 2024, 4:00 PM
1.610
+0.160 (11.03%)
Pre-market: Nov 7, 2024, 8:52 AM EST

Celularity Revenue

Celularity had revenue of $14.68M in the quarter ending March 31, 2024, with 273.09% growth. This brings the company's revenue in the last twelve months to $33.52M, up 109.81% year-over-year. In the year 2023, Celularity had annual revenue of $22.77M with 26.68% growth.

Revenue (ttm)
$33.52M
Revenue Growth
+109.81%
P/S Ratio
0.83
Revenue / Employee
$279,308
Employees
120
Market Cap
31.88M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202322.77M4.80M26.68%
Dec 31, 202217.98M-3.36M-15.75%
Dec 31, 202121.34M7.06M49.43%
Dec 31, 202014.28M-6.87M-32.48%
Dec 31, 201921.15M3.59M20.47%
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
FibroGen 173.82M
Nortech Systems 137.53M
Outset Medical 116.43M
Lipocine 4.80M
Dyadic International 1.80M
Longeveron 1.23M
Nexalin Technology 150.16K
Revenue Rankings

CELU News

More News